SearcharxivSearch

arXiv subjects

Heet Sankesara

Publications and source records attributed to Heet Sankesara.

9 recordsLinked to original sources

Physical Activity Trajectories Preceding Incident Major Depressive Disorder Diagnosis Using Consumer Wearable Devices in the All of Us Research Program: Case-Control Study

Low physical activity is a known risk factor for major depressive disorder (MDD), but changes in activity before a first clinical diagnosis remain unclear, especially using long-term objective measurements. This study characterized trajectories of wearable-measured physical activity during the year preceding incident MDD diagnosis. We conducted a retrospective nested case-control study using linked electronic health record and Fitbit data from the All of Us Research Program. Adults with at least 6 months of valid wearable data in the year before diagnosis were eligible. Incident MDD cases were matched to controls on age, sex, body mass index, and index time (up to four controls per case). Daily step counts and moderate-to-vigorous physical activity (MVPA) were aggregated into monthly averages. Linear mixed-effects models compared trajectories from 12 months before diagnosis to diagnosis. Within cases, contrasts identified when activity first significantly deviated from levels 12 months prior. The cohort included 4,104 participants (829 cases and 3,275 controls; 81.7% women; median age 48.4 years). Compared with controls, cases showed consistently lower activity and significant downward trajectories in both step counts and MVPA during the year before diagnosis (P < 0.001). Significant declines appeared about 4 months before diagnosis for step counts and 5 months for MVPA. Exploratory analyses suggested subgroup differences, including steeper declines in men, greater intensity reductions at older ages, and persistently low activity among individuals with obesity. Sustained within-person declines in physical activity emerged months before incident MDD diagnosis. Longitudinal wearable monitoring may provide early signals to support risk stratification and earlier intervention.

stat.AP

An Explainable Anomaly Detection Framework for Monitoring Depression and Anxiety Using Consumer Wearable Devices

Continuous monitoring of behavior and physiology via wearable devices offers a novel, objective method for the early detection of worsening depression and anxiety. In this study, we present an explainable anomaly detection framework that identifies clinically meaningful increases in symptom severity using consumer-grade wearable data. Leveraging data from 2,023 participants with defined healthy baselines, our LSTM autoencoder model learned normal health patterns of sleep duration, step count, and resting heart rate. Anomalies were flagged when self-reported depression or anxiety scores increased by >=5 points (a threshold considered clinically significant). The model achieved an adjusted F1-score of 0.80 (precision = 0.73, recall = 0.88) in detecting 393 symptom-worsening episodes across 341 participants, with higher performance observed for episodes involving concurrent depression and anxiety escalation (F1 = 0.84) and for more pronounced symptom changes (>=10-point increases, F1 = 0.85). Model interpretability was supported by SHAP-based analysis, which identified resting heart rate as the most influential feature in 71.4 percentage of detected anomalies, followed by physical activity and sleep. Together, our findings highlight the potential of explainable anomaly detection to enable personalized, scalable, and proactive mental health monitoring in real-world settings.

cs.CV

Large-scale digital phenotyping: identifying depression and anxiety indicators in a general UK population with over 10,000 participants

Digital phenotyping offers a novel and cost-efficient approach for managing depression and anxiety. Previous studies, often limited to small-to-medium or specific populations, may lack generalizability. We conducted a cross-sectional analysis of data from 10,129 participants recruited from a UK-based general population between June 2020 and August 2022. Participants shared wearable (Fitbit) data and self-reported questionnaires on depression (PHQ-8), anxiety (GAD-7), and mood via a study app. We first examined the correlations between PHQ-8/GAD-7 scores and wearable-derived features, demographics, health data, and mood assessments. Subsequently, unsupervised clustering was used to identify behavioural patterns associated with depression or anxiety. Finally, we employed separate XGBoost models to predict depression and anxiety and compared the results using different subsets of features. We observed significant associations between the severity of depression and anxiety with several factors, including mood, age, gender, BMI, sleep patterns, physical activity, and heart rate. Clustering analysis revealed that participants simultaneously exhibiting lower physical activity levels and higher heart rates reported more severe symptoms. Prediction models incorporating all types of variables achieved the best performance ($R^2$=0.41, MAE=3.42 for depression; $R^2$=0.31, MAE=3.50 for anxiety) compared to those using subsets of variables. This study identified potential indicators for depression and anxiety, highlighting the utility of digital phenotyping and machine learning technologies for rapid screening of mental disorders in general populations. These findings provide robust real-world insights for future healthcare applications.

q-bio.QM

Longitudinal Assessment of Seasonal Impacts and Depression Associations on Circadian Rhythm Using Multimodal Wearable Sensing

Objective: This study aimed to explore the associations between depression severity and wearable-measured circadian rhythms, accounting for seasonal impacts and quantifying seasonal changes in circadian rhythms.Materials and Methods: Data used in this study came from a large longitudinal mobile health study. Depression severity (measured biweekly using the 8-item Patient Health Questionnaire [PHQ-8]) and behaviors (monitored by Fitbit) were tracked for up to two years. Twelve features were extracted from Fitbit recordings to approximate circadian rhythms. Three nested linear mixed-effects models were employed for each feature: (1) incorporating the PHQ-8 score as an independent variable; (2) adding the season variable; and (3) adding an interaction term between season and the PHQ-8 score. Results: This study analyzed 10,018 PHQ-8 records with Fitbit data from 543 participants. Upon adjusting for seasonal effects, higher PHQ-8 scores were associated with reduced activity, irregular behaviors, and delayed rhythms. Notably, the negative association with daily step counts was stronger in summer and spring than in winter, and the positive association with the onset of the most active continuous 10-hour period was significant only during summer. Furthermore, participants had shorter and later sleep, more activity, and delayed circadian rhythms in summer compared to winter. Discussion and Conclusions: Our findings underscore the significant seasonal impacts on human circadian rhythms and their associations with depression and indicate that wearable-measured circadian rhythms have the potential to be the digital biomarkers of depression.

stat.AP

Identifying depression-related topics in smartphone-collected free-response speech recordings using an automatic speech recognition system and a deep learning topic model

Language use has been shown to correlate with depression, but large-scale validation is needed. Traditional methods like clinic studies are expensive. So, natural language processing has been employed on social media to predict depression, but limitations remain-lack of validated labels, biased user samples, and no context. Our study identified 29 topics in 3919 smartphone-collected speech recordings from 265 participants using the Whisper tool and BERTopic model. Six topics with a median PHQ-8 greater than or equal to 10 were regarded as risk topics for depression: No Expectations, Sleep, Mental Therapy, Haircut, Studying, and Coursework. To elucidate the topic emergence and associations with depression, we compared behavioral (from wearables) and linguistic characteristics across identified topics. The correlation between topic shifts and changes in depression severity over time was also investigated, indicating the importance of longitudinally monitoring language use. We also tested the BERTopic model on a similar smaller dataset (356 speech recordings from 57 participants), obtaining some consistent results. In summary, our findings demonstrate specific speech topics may indicate depression severity. The presented data-driven workflow provides a practical approach to collecting and analyzing large-scale speech data from real-world settings for digital health research.

cs.CL

Challenges in Using mHealth Data From Smartphones and Wearable Devices to Predict Depression Symptom Severity: Retrospective Analysis

A number of challenges exist for the analysis of mHealth data: maintaining participant engagement over extended time periods and therefore understanding what constitutes an acceptable threshold of missing data; distinguishing between the cross-sectional and longitudinal relationships for different features to determine their utility in tracking within-individual longitudinal variation or screening individuals at high risk; and understanding the heterogeneity with which depression manifests itself in behavioral patterns quantified by the passive features. From 479 participants with MDD, we extracted 21 features capturing mobility, sleep, and smartphone use. We investigated the impact of the number of days of available data on feature quality using the intraclass correlation coefficient and Bland-Altman analysis. We then examined the nature of the correlation between the 8-item Patient Health Questionnaire (PHQ-8) depression scale (measured every 14 days) and the features using the individual-mean correlation, repeated measures correlation, and linear mixed effects model. Furthermore, we stratified the participants based on their behavioral difference, quantified by the features, between periods of high (depression) and low (no depression) PHQ-8 scores using the Gaussian mixture model. We demonstrated that at least 8 (range 2-12) days were needed for reliable calculation of most of the features in the 14-day time window. We observed that features such as sleep onset time correlated better with PHQ-8 scores cross-sectionally than longitudinally, whereas features such as wakefulness after sleep onset correlated well with PHQ-8 longitudinally but worse cross-sectionally. Finally, we found that participants could be separated into 3 distinct clusters according to their behavioral difference between periods of depression and periods of no depression.

q-bio.QM

Disease Insight through Digital Biomarkers Developed by Remotely Collected Wearables and Smartphone Data

Digital Biomarkers and remote patient monitoring can provide valuable and timely insights into how a patient is coping with their condition (disease progression, treatment response, etc.), complementing treatment in traditional healthcare settings.Smartphones with embedded and connected sensors have immense potential for improving healthcare through various apps and mHealth (mobile health) platforms. This capability could enable the development of reliable digital biomarkers from long-term longitudinal data collected remotely from patients. We built an open-source platform, RADAR-base, to support large-scale data collection in remote monitoring studies. RADAR-base is a modern remote data collection platform built around Confluent's Apache Kafka, to support scalability, extensibility, security, privacy and quality of data. It provides support for study design and set-up, active (eg PROMs) and passive (eg. phone sensors, wearable devices and IoT) remote data collection capabilities with feature generation (eg. behavioural, environmental and physiological markers). The backend enables secure data transmission, and scalable solutions for data storage, management and data access. The platform has successfully collected longitudinal data for various cohorts in a number of disease areas including Multiple Sclerosis, Depression, Epilepsy, ADHD, Alzheimer, Autism and Lung diseases. Digital biomarkers developed through collected data are providing useful insights into different diseases. RADAR-base provides a modern open-source, community-driven solution for remote monitoring, data collection, and digital phenotyping of physical and mental health diseases. Clinicians can use digital biomarkers to augment their decision making for the prevention, personalisation and early intervention of disease.

cs.CY

Associations between depression symptom severity and daily-life gait characteristics derived from long-term acceleration signals in real-world settings

Gait is an essential manifestation of depression. Laboratory gait characteristics have been found to be closely associated with depression. However, the gait characteristics of daily walking in real-world scenarios and their relationships with depression are yet to be fully explored. This study aimed to explore associations between depression symptom severity and daily-life gait characteristics derived from acceleration signals in real-world settings. In this study, we used two ambulatory datasets: a public dataset with 71 elder adults' 3-day acceleration signals collected by a wearable device, and a subset of an EU longitudinal depression study with 215 participants and their phone-collected acceleration signals (average 463 hours per participant). We detected participants' gait cycles and force from acceleration signals and extracted 20 statistics-based daily-life gait features to describe the distribution and variance of gait cadence and force over a long-term period corresponding to the self-reported depression score. The gait cadence of faster steps (75th percentile) over a long-term period has a significant negative association with the depression symptom severity of this period in both datasets. Daily-life gait features could significantly improve the goodness of fit of evaluating depression severity relative to laboratory gait patterns and demographics, which was assessed by likelihood-ratio tests in both datasets. This study indicated that the significant links between daily-life walking characteristics and depression symptom severity could be captured by both wearable devices and mobile phones. The gait cadence of faster steps in daily-life walking has the potential to be a biomarker for evaluating depression severity, which may contribute to clinical tools to remotely monitor mental health in real-world settings.

q-bio.QM

The utility of wearable devices in assessing ambulatory impairments of people with multiple sclerosis in free-living conditions

Multiple sclerosis (MS) is a progressive inflammatory and neurodegenerative disease of the central nervous system affecting over 2.5 million people globally. In-clinic six-minute walk test (6MWT) is a widely used objective measure to evaluate the progression of MS. Yet, it has limitations such as the need for a clinical visit and a proper walkway. The widespread use of wearable devices capable of depicting patients activity profiles has the potential to assess the level of MS-induced disability in free-living conditions. In this work, we extracted 96 activity features in different temporal granularities (from minute-level to day-level) and explored their utility in estimating 6MWT scores in a European (Italy, Spain, and Denmark) MS cohort of 337 participants over an average of 10-month duration. We combined these features with participant demographics using three regression models including elastic net, gradient boosted trees and random forest. In addition, we quantified the individual feature contribution using feature importance in these regression models, linear mixed-effects models, generalized estimating equations, and correlation-based feature selection (CFS). The results showed promising estimation performance with R2 of 0.30, which was derived using random forest after CFS. This model was able to distinguish the participants with low disability from those with high disability. Furthermore, we observed that the minute-level (no longer than 8 minutes) step count, particularly those capturing the upper end of the step count distribution, had a stronger association with 6MWT. The use of a walking aid was indicative of ambulatory function measured through 6MWT. This study provides a basis for future investigation into the clinical relevance and utility of wearables in assessing MS progression in free-living conditions.

q-bio.QM